- Home
- VICR vs VCYT Comparison
VICR vs VCYT Comparison
Compare VICR & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VICR
- VCYT
- Stock Information
- Founded
- VICR 1981
- VCYT 2006
- Country
- VICR United States
- VCYT United States
- Employees
- VICR N/A
- VCYT N/A
- Industry
- VICR Industrial Machinery/Components
- VCYT Medical Specialities
- Sector
- VICR Technology
- VCYT Health Care
- Exchange
- VICR Nasdaq
- VCYT Nasdaq
- Market Cap
- VICR 2.3B
- VCYT 2.4B
- IPO Year
- VICR N/A
- VCYT 2013
- Fundamental
- Price
- VICR $52.06
- VCYT $32.28
- Analyst Decision
- VICR Hold
- VCYT Buy
- Analyst Count
- VICR 2
- VCYT 9
- Target Price
- VICR $43.00
- VCYT $39.89
- AVG Volume (30 Days)
- VICR 304.0K
- VCYT 931.4K
- Earning Date
- VICR 10-21-2025
- VCYT 11-05-2025
- Dividend Yield
- VICR N/A
- VCYT N/A
- EPS Growth
- VICR 576.06
- VCYT N/A
- EPS
- VICR 1.45
- VCYT 0.34
- Revenue
- VICR $379,346,000.00
- VCYT $479,129,000.00
- Revenue This Year
- VICR $20.25
- VCYT $14.19
- Revenue Next Year
- VICR $4.82
- VCYT $9.68
- P/E Ratio
- VICR $35.89
- VCYT $96.01
- Revenue Growth
- VICR 2.46
- VCYT 19.91
- 52 Week Low
- VICR $36.08
- VCYT $22.61
- 52 Week High
- VICR $65.70
- VCYT $47.32
- Technical
- Relative Strength Index (RSI)
- VICR 60.61
- VCYT 61.38
- Support Level
- VICR $49.36
- VCYT $30.67
- Resistance Level
- VICR $51.38
- VCYT $32.34
- Average True Range (ATR)
- VICR 1.41
- VCYT 1.13
- MACD
- VICR -0.03
- VCYT -0.03
- Stochastic Oscillator
- VICR 73.37
- VCYT 88.71
About VICR Vicor Corporation
Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.